A clinical trial involving nesiritide was registered under the title "Acute Cardiac Effects of Ultra-Trail Running," according to a record dated August 7, 2026. The study, identified as NCT07753694, is listed with a status of not yet recruiting. No phase was specified in the registration.
Nesiritide remains classified as an unapproved research compound. This trial update reflects only the registration status as of the listed date. It does not indicate that enrollment has begun or that any participants have been assessed.
No outcomes, results, or safety data have been reported for this trial at this stage. The record does not provide information on study design details beyond the title and status. As the trial has not yet started recruiting, no interim or final findings are available for review.
Readers should note that trial registration alone does not confirm any therapeutic effect, benefit, or risk associated with nesiritide. Further updates may become available as the trial progresses toward recruitment and, eventually, results reporting. For additional context on this compound, readers can consult the compound overview.